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Basophils are potent effector cells of innate immunity and also play a role in T helper 2
(Th2)-mediated allergic responses. But, although their in vitro functions are well studied,
their in vivo functions remain largely unknown. However, several mouse models of
basophil depletion have recently been developed and used to investigate basophil
functions. For example, in a croton oil-induced model of irritant contact dermatitis in
conditionally basophil-depleted transgenic mice, we found that basophils rapidly infiltrate
inflamed skin and subsequently induce infiltration of eosinophils. We also showed that
basophils induce Th2 skewing upon epicutaneous sensitization with various haptens and
peptide antigens. Intriguingly, basophils also promoted Th2 polarization upon protein
antigen exposure in the presence of dendritic cells (DCs). The dermal DC subset
associated with Th2 skewing was recently identified as CD301b+ DC. Such studies
with basophil-deficient mouse models have significantly improved our understanding
of the mechanisms involved in human immune-related diseases. In this review, we
will focus on the relative contribution of basophils and DCs to Th2-mediated allergic
responses.
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Introduction
T helper 2 (Th2) immune responses, which develop in response to allergens and parasites, are
characterized by high levels of immunoglobulin E (IgE) and the presence of Th2 cells (1). Basophils
are intimately involved in Th2 immune responses, and upon activation of the high-affinity receptor
for IgE (FcεRI) or other surface receptors, they release multiple effector molecules, including
proteases, vasodilating substances, such as histamine, cytokines, pro-inflammatory chemokines,
and lipid mediators (2, 3). However, the mechanisms that initiate Th2 responses are not fully
understood. Previous reports have shown that dendritic cells (DCs), the most efficient antigen-
presenting cells (APCs) in the immune system, play a crucial role (4). However, recent experi-
ments in newly developed basophil-deficient mouse models have highlighted the importance of
basophils as well. For example, Th2 skewing is considered to be mainly induced by DCs, but
recent studies in basophil-depletion mouse models indicate that basophils also play a pivotal role
in this process (5–7). Here, we review the roles of basophils in cutaneous immune reactions
and Th2-mediated allergic responses associated with cutaneous allergic diseases, focusing on
the possibility that basophils and DCs function cooperatively in inducing Th2-mediated allergic
responses.
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Cutaneous Allergic Diseases Associated
with Basophil Infiltration
Basophils have been detected in the vicinity of eosinophils in
several human cutaneous allergic diseases, and infiltration of
basophils has been reported in several skin diseases, including
atopic dermatitis (AD), prurigo, and urticaria (8). It is noteworthy
that skin lesions of bullous pemphigoid, classical eosinophilic
pustular folliculitis (Ofuji’s disease), and Henoch–Schönlein pur-
pura also frequently exhibit tissue basophilia (8–11) (Table 1).
We recently demonstrated the presence of both basophils and
eosinophils in inflamed skin of patients with irritant contact
dermatitis (ICD) (12). Further, we showed that basophils rapidly
infiltrate into the inflamed skin, and subsequently induce infiltra-
tion of eosinophils with a croton oil-induced model of ICD. But
it is still unclear exactly how basophils infiltrate into the lesional
skin. There are several candidate basophil attractants, such as
α(1,3)-fucosyltransferases IV and VII, for the initial recruitment
of basophils in chronic allergic inflammation (CAI) (13). Sub-
sequently, basophils attract eosinophils directly or indirectly via
eotaxin-mediated interaction with mesenchymal fibroblasts (12).
IgE-Mediated Chronic Allergic
Inflammation and Chronic Idiopathic
Urticaria
Immunoglobulin E-mediated chronic allergic inflammation (IgE-
CAI) is a novel type of chronic inflammation of the skin that fol-
lows the immediate-type and late-phase responses in mice (14). It
has been reported that IgE-CAI is independent of mast cells and T
cells, but is dependent on basophils expressing FceRIa and CD49b
phenotypic markers (14). Interestingly, although the number of
basophils infiltrating the lesional skin is very low, their depletion
led to a marked reduction in inflammation, concomitantly with
decreased numbers of eosinophils and neutrophils and attenu-
ation of the increased ear thickness (14). Recent studies have
shown that inflammatory monocytes recruited to IgE-CAI lesions
acquire an anti-inflammatory phenotype via basophil-derived IL-
4 (15). Collectively, these results suggest a specific and non-
redundant role for basophils in the initiation and maintenance of
chronic IgE-mediated inflammatory responses in mice (16).
It is important to note that there are some functional differences
between human basophils and mouse basophils. In mice, acti-
vated basophils produce platelet-activating factors and contribute
to the development of anaphylaxis in response to penicillin-IgG
antibody complexes. On the other hand, human basophils do
not respond to IgG immune complexes (17, 18). Nevertheless,
some findings in mouse basophils appear to shed light on the
pathogenesis of human cutaneous diseases. Antibodies to FcεRIα
were found in 40% of patients with chronic idiopathic urticaria
(CIU). Some CIU patients exhibited urticaria in response to anti-
FcεRIα IgG and/or IgE antibodies, which may stimulate mast
cells or basophils (19). In addition, an activation marker on
basophils, CD203c, was upregulated upon incubation of donor
basophils with sera from patients with CIU (20). Furthermore,
infiltration of basophils is increased in urticarial lesions of CIU
(8, 21). Consistently with this finding, basopenia in CIU appears
TABLE 1 | Dermatological diseases accompanied with basophil infiltration.
Atopic dermatitis (8)
Irritant contact dermatitis (12)
Prurigo (8)
Urticaria (8)
Pemphigus vulgaris (8)
Bullous vulgaris (8)
Drug eruption (8)
Henoch–Schönlein purpura (8)
Insect bite (tick bite) (11)
Scabies (8)
Dermatomyositis (8)
Eosinophilic pustular folliculitis (10)
Leprosy (LL type) (9)
to be due to the migration of basophils from the peripheral blood
to urticarial lesions (1, 8, 21). Therefore, the phenomena seen
in the mouse IgE-CAI model might explain the pathogenesis of
human CIU.
Dendritic Cell-Specific and
Basophil-Specific Depletion Models
Although the CD11c-based system is themost common depletion
model of DCs, it has the disadvantage of imperfectly separating
conventional DCs (cDCs) andmacrophages (22, 23). On the other
hand, since there are no natural mouse mutants with basophil
deficiencies, antibodies that recognize either FcεRI (clone MAR-
1) or the orphan-activating receptorCD200 receptor 3 (CD200R3)
(clone Ba103) have been used to investigate the role of basophils.
However, these antibody clones not only deplete basophils but also
stimulate mast cells (24, 25). In addition, Ba103 activates myeloid
cells and NK cells (26), and MAR-1 depletes a subset of FcεRI-
positive DCs (27). Table 2 summarizes currently available mouse
strains with constitutive or inducible depletion of basophils. Three
groups have developed basophil-depletion models through reg-
ulation of Mcpt8, a basophil-specific gene in the conserved chy-
mase locus (24, 28–30). In these mice, basophils were depleted
in peripheral blood without side effects. A different basophil-
depletion model utilizing the P1-Runx gene was reported by
Mukai et al. (31) These mice show depletion of basophils, but not
eosinophils, neutrophils, or mast cells. Sawaguchi et al. developed
Bas-TRECK Tg mice, using a diphtheria-toxin receptor (DTR)
transgene under the control of the DNase I-hypersensitive site 4
(HS4) region of IL-4 (32).
Basophils are Associated with Th2
Skewing in Response to Haptens
Mature DCs are generally considered to be required for naïve T
cells to proliferate and acquire Th2 effector functions in response
to antigen encounters (33). Recently, however, the function of
DCs in Th2 induction has been questioned because basophils
also appear to play a pivotal role in this process (5–7). Basophils
migrate into draining lymph nodes (LNs) from the site of papain
injection or helminth infection and act as APCs by taking up
and processing antigens (5–7). In addition, basophils are capable
of expressing MHC class II and costimulatory molecules, such
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TABLE 2 |Mouse models of basophil depletion.
Model system Experimental strategy Method of depletion Depletion
efficiency
Reference
Basoph8 Knock-in of IRES–YFP–Cre cassette before the Mcpt8 start codon Cross to R-DTA mice >90% (28)
Mcpt8-Cre BAC transgene (Cre inserted after the Mcpt8 start codon) Constitutive depletion >90% (24)
Mcpt8DTR Knock-in of IRES–DTR–EGFP cassette in 30-UTR of Mcpt8 DT injection >90% (29)
P1-Runx1 Knockout P1-Runx1 seems to be essential
for the basophil lineage
>90% (31)
Bas-TRECK DTR transgene (under control of HS4 region of IL-4) DT injection >90% (32)
BAC, bacterial artificial chromosome; DTR, diphtheria toxin receptor; IL-4, interleukin-4; IRES, internal ribosome entry site; Mcpt, mast cell protease; NA, not applicable; NR, not reported;
R-DTA, ROSA-diphtheria toxin-α; UTR, untranslated region; YFP, yellow fluorescent protein.
as CD40, CD80, and CD86. They also secrete several cytokines
critical for Th2 development, including IL-4 and thymic stromal
lymphopoietin (TSLP). Thus, under certain conditions, basophils
alone, without DCs, can cause Th2 induction from naïve T
cells. However, the role of basophils in Th2 skewing has again
been questioned since several of the above experiments used
bone marrow-derived basophils (BMBaso) containing FcεRI-
expressing inflammatory DC (27).
Recently, we demonstrated that basophils play a role in Th2
skewing in response to haptens and peptide antigens, but not pro-
tein antigens, in a basophil-deficient mouse model, Bas TRECK
Tg (34). In addition, we showed that basophils were capable of
Th2 skewing by using CD11c-depleted BMBaso in order to avoid
contamination with inflammatory DCs. Basophils express MHC
class II, CD40, CD80, CD86, and IL-4 in the hapten-induced
cutaneous Th2 model. However, using the DQ-OVA system, we
confirmed that basophils did not efficiently take up or process
protein antigens (34). A different experimental system using OVA
coupled to fluorescein isothiocyanate showed that basophils could
take up protein antigens (6), but our results showed that hapten
antigens and peptides might bind directly to MHC class II on
basophils, and they could be acquired and presented by basophils.
On the other hand, basophils hardly digest protein and so cannot
efficiently present protein antigens (Figures 1 and 2). Although
the OVA-peptide system is totally artificial, complex inflamma-
tory environments, such as post-Schistosomamansoni or Trichuris
muris infection, probably contain small soluble antigens as well as
larger proteins. In addition, cutaneous immunization with papain
protease allergen promotes MHC class II expression on basophils
in LNs, probably after the generation of peptide antigens from
the protein in vivo (6). A recent report showed that basophils are
capable of inducing Th2 upon exposure to OVA proteins com-
plexed with specific IgE (7). They pulsed basophils with various
doses of DNP-OVA in the presence of monoclonal antibody to
DNP (IgE anti-DNP) and showed that Th2 skewing by basophils
was enhanced with the effect of IgE anti-DNP, especially when
basophils were pulsed with low concentrations of DNP-OVA (7).
House dust mites, which possess cysteine protease activity, are
incapable of inducing Th2 when presented by basophils, even
though cysteine protease may play a role in processing protein
antigen into peptides in vivo (27), because the expressions ofHLA-
DM and of the invariant chain on basophils, those were sorted
from the LNs 3 days after house dust mites administration, were
very low (27).
Basophil
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FIGURE 1 | Basophils promote Th2 skewing in response to haptens
and peptide antigens. Basophils promote Th2 skewing upon peptide and
hapten exposure by expressing MHC class II, CD40, CD80, CD86, and IL-4.
Although several studies show that murine basophils can serve
as APCs, the situation is less clear for human basophils. Human
basophils express MHC class II (35, 36), but it was not able
to induce antigen-specific T cell activation or proliferation in
response to house dust mite allergen exposure (36). Another
group reported that HLA-DR in human basophils is upregulated
by IL-3 and IFN-γ, but the basophils cannot work as APCs for
pollen allergen (37). It has been confirmed that human basophils
lack some features of APCs (38, 39). Additional studies are needed
to determine whether human basophils can act as APCs under
various pathophysiological conditions.
Interaction between DCs and
Basophils for Th2 Skewing
It has been reported that basophils contribute to the strength
of the Th2 response in the lungs, but they cannot present anti-
gens or express chaperones involved in antigen presentation (27).
Therefore, it was suggested that DCs are necessary and sufficient
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FIGURE 2 | Basophils promote Th2 skewing in response to protein
antigens in the presence of dendritic cells. Upon exposure to OVA
protein, basophils do not work as APCs, since basophils cannot take up or
process OVA protein. In the presence of dendritic cells, however, basophils
promote Th2 skewing. The precise mechanisms of interaction between
basophils and dendritic cells remain unclear.
for inducing Th2 immunity to house dust mites in the lungs,
and basophils are not required. In accordance with this idea,
Th2 responses were severely impaired after Schistosoma mansoni
egg injection and during active Schistosoma mansoni infection
by depletion of CD11c+ cells, but not by depletion of basophils
with anti-FcεRIα antibody (4). These findings suggest that some
DC subsets induce Th2 skewing upon exposure to protein
antigens.
Recently, two different groups have shown that Th2 skewing
in response to Nippostrongylus brasiliensis infection depends on
dermal CD301b+ DCs (40, 41). Depletion of CD301b+ DCs prior
to infection reduces the number of IL-4-producing CD4+ T cells
(40, 41). CD301b+ DCs also express programed death ligand-
2 (PDL2), and a subset of PDL2+CD301b+ DCs that express
the transcription factor interferon regulatory factor 4 (IRF4) was
shown to be required for Th2 induction in vivo (41). In accor-
dance with these findings, CD11c+MHC class II+ dermal DCs
expressing PDL2, and CD301b were identified as a Th2-inducing
DC subset inNippostrongylus brasiliensis infection (42). However,
CD301b+ DCs alone are incapable of inducing a Th2 response
in vitro (41) or in vivo (40).
We have shown that basophils are capable of inducing Th2
skewing upon exposure to protein antigens in the presence of
DCs (34). Because basophils are not able to take up or pro-
cess protein antigens efficiently, DCs may prepare peptides from
protein antigens for antigen presentation by basophils or may
promote IL-4 production from basophils to skew Th2. In line
with this, we had previously demonstrated that Langerhans cells,
an epidermal DC subset, mediate epicutaneous sensitization with
OVA protein antigen to induce Th2-type immune responses (43).
Further studies are needed to show direct evidence whether DCs
prepare peptides from protein antigens for the Th2 induction by
basophils. In addition, Th2 reaction in response to schistosome
infection or protein antigens was reduced in a CD11c-depletion
model (4, 27). Therefore, DCs seem to be necessary for inducing
Th2 reaction upon exposure to protein antigen both in vivo and
in vitro.
Furthermore, basophils were found in the vicinity of T-cells
in the T-cell zone of draining LNs by epicutaneous sensitization
with haptens (34). Optimal localization of DCs within LNs may
play a crucial role in Th2 skewing in each condition. CXCR5-
expressing CD11c+ DCs migrate to the LNs and localize adjacent
to B cell follicles inHeligmosomoides polygyrus infection, whereas
depletion of CXCR5 or B cell-derived lymphotoxin alters the
localization of DCs and impairs the development of Th2 cells (44).
Therefore, although the location of DCs on draining LNs for Th2
induction is still controversial, it is possible that basophils, T cells,
and DCs promote Th2 induction in a coordinated way. Similarly,
reactive oxygen species (ROS) were generated in dermal DCs and
in LN DCs upon subcutaneous exposure to papain plus antigen.
ROS promoted Th2 response via formation of oxidized lipids
that triggered TSLP production by epithelial cells. In addition,
ROS enhanced Th2 induction by inducing release of CCL7 from
DCs, leading to the recruitment of basophils to the draining LNs
(45). Another group showed that IL-3 plays a role in basophil
recruitment to draining LNs using helminth infection model with
mice deficient in IL-3 or IL-3Rβ (46). However, they found that
helminth-induced Th2 response was not diminished in an MAR-
1 antibody-induced basophil-depletionmodel. Further studies are
needed to determine whether DCs present peptides to basophils
directly or whether plasma membrane fragments are transferred
from APCs to lymphocytes by trogocytosis.
Conclusion
Studies in basophil-deficient mouse models over the last decade
have greatly improved our understanding of the mechanisms of
development of Th2 immune reactions. Nevertheless, some key
questions remain unanswered, including howDCs cooperate with
basophils during Th2 skewing, especially in response to protein
antigen exposure. In addition, the precise role of basophils in Th2
skewing, especially their function as APCs, remains controversial
(27, 46). One possibility is that basophils may work as early
IL-4-producing cells for the induction of Th2. An issue in some
previous studies has been the imperfect separation of cDC in
CD11c-based systems, and one possible approach to overcome
this would be to use CD11c-DTR and Zbtb46-DTR, a marker
specifically expressed by cDCs in lymphoid and non-lymphoid
tissues but not by other myeloid or lymphoid cell types (47).
Newly developed DC-deficient and basophil-deficient models
are expected to provide further information on the mechanisms
involved in Th2 skewing. Such studies may provide a basis for
novel therapeutic approaches to controlling allergic diseases.
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